Nature Research

Nature Research
Name	Nature Research
Type	Publishing imprint
Founded	1869 (as Nature)
Founder	Alexander Macmillan
Headquarters	London
Key people	Philip Campbell, Magdalena Skipper, Heidi Ledford
Products	Scientific journals, magazines, online content
Parent	Springer Nature

Nature Research

Nature Research is a publishing imprint known for producing a portfolio of scientific journals, magazines, and online platforms associated with high-impact scholarly communication. It operates flagship titles with substantial influence across biomedical, physical, and life sciences communities and interacts with major research institutions, funding agencies, and libraries. Through ties with global organizations and scholarly societies, its brands feature prominently in citation indices and academic hiring benchmarks.

History

Nature Research traces roots to the founding of the journal Nature by Alexander Macmillan and colleagues in 1869, emerging amid Victorian-era developments such as the Royal Society's expansion and debates involving figures like Charles Darwin and Thomas Huxley. Over the 20th century the imprint grew alongside institutions including Oxford University Press, Cambridge University Press, and the rise of modern research universities such as Harvard University, University of Oxford, and University of Cambridge. Post-war scientific shifts tied to initiatives like the Manhattan Project, the Human Genome Project, and the establishment of agencies such as the National Institutes of Health influenced editorial focus and readership. Corporate consolidation in the late 20th and early 21st centuries linked the imprint to conglomerates comparable to Elsevier, Wiley-Blackwell, and Taylor & Francis Group. In 2015 merger activity involving publishers akin to Springer Science+Business Media and legacy houses culminated in structures paralleling Springer Nature, shaping contemporary strategy and market positioning.

Publications and Journals

The portfolio includes multidisciplinary and specialist titles analogous to flagship publications like Science (journal), The Lancet, and discipline-specific outlets comparable to Cell (journal), Nature Genetics, Nature Medicine, Nature Physics, and Nature Communications. Subject coverage spans areas represented by institutions and initiatives such as European Molecular Biology Laboratory, CERN, NASA, Wellcome Trust, and Max Planck Society. The imprint curates articles alongside review venues like Annual Reviews and society journals from bodies such as the American Chemical Society, Royal Society of Chemistry, and Institute of Electrical and Electronics Engineers. Editorial pages, commentaries, and news reporting intersect with media organizations like BBC News, The New York Times, and The Guardian when research influences public policy debates tied to events such as the Paris Agreement and outbreaks like the COVID-19 pandemic. Indexing and impact metrics often draw on services such as Web of Science, Scopus, and PubMed Central while awards recognize work comparable to Nobel Prize, Lasker Award, and Breakthrough Prize winners.

Editorial Policies and Peer Review

Editorial operations involve processes comparable to those at Proceedings of the National Academy of Sciences, PNAS, and Cell Press, employing peer review systems used across academia involving editors connected to universities such as Stanford University, Massachusetts Institute of Technology, and University of California, Berkeley. Policies address conflicts of interest, reproducibility concerns highlighted by cases at institutions like University of Cambridge and Princeton University, and procedures for corrections and retractions similar to practices at Retraction Watch and committees such as the Committee on Publication Ethics. Editorial standards reference guidelines from bodies such as the Committee on Publication Ethics and funding mandates from agencies including the European Research Council and National Science Foundation. Peer review models include single-blind, double-blind, and open review experiments comparable to initiatives at F1000Research and preprint practices tied to arXiv and bioRxiv.

Open Access and Licensing

Open access strategies align with policies from funders and consortia such as the Wellcome Trust, Plan S, and the European Commission. Licensing frameworks employ Creative Commons models as advocated by organizations like Creative Commons and repositories such as PubMed Central and institutional archives at universities including University of California systems. Transformative agreements and offset models mirror negotiations made by national consortia like Germany's Projekt DEAL and libraries within the Association of Research Libraries. Article processing charges and waivers are debated in contexts referenced by groups like SPARC and OpenAIRE.

Corporate Structure and Ownership

The imprint functions within a larger corporate entity comparable to conglomerates formed by mergers of publishers such as Springer Science+Business Media and legacy houses associated with families like the Macmillan Publishers lineage. Ownership and governance involve boards, executive leadership, and shareholder interests related to media companies and investment firms similar to those that have influenced consolidation in academic publishing alongside corporations like Bertelsmann and Holtzbrinck Publishing Group. Partnerships with societies, university presses, and indexing services such as Clarivate affect strategic decisions on subscriptions, licensing, and global distribution through platforms like library networks at JSTOR and consortia in regions including North America, Europe, and Asia.

Criticism and Controversies

Critiques parallel those leveled at major publishers such as Elsevier and Wiley regarding subscription pricing, access barriers cited by advocacy groups like Sci-Hub and ResearchGate, and debates around metrics-driven incentives tied to impact factor-centric evaluation used by hiring committees at universities like University College London and grant panels at the National Institutes of Health. High-profile corrections, retractions, and editorial disputes have involved institutions and researchers affiliated with entities such as Imperial College London, Johns Hopkins University, and research consortia addressing reproducibility crises highlighted by panels from the National Academy of Sciences. Negotiations over open access and transformative deals have sparked controversy with national negotiation bodies including Projekt DEAL and funder coalitions like cOAlition S.

Category:Academic publishing companies